Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution
文献类型:期刊论文
作者 | Zhang Ye2![]() |
刊名 | CHINESE MEDICAL JOURNAL
![]() |
出版日期 | 2011 |
卷号 | 124 |
关键词 | RADIOTHERAPY TUMORS hypo-fractionated stereotactic body radiation therapy lung metastases prognosis |
ISSN号 | 0366-6999 |
其他题名 | Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution |
英文摘要 | Background Metastatic lung cancer is one of the most common oncologic problems. This study aimed to evaluate the long-term clinical outcome of stereotactic body radiation therapy (SBRT) for metastatic lung tumors. |
资助项目 | [Ministry of Science and Technology of China] ; [Capital Medical Development Scientific Research Fund of China] |
语种 | 英语 |
CSCD记录号 | CSCD:4401003 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/45653] ![]() |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Peking Union Med Coll, Beijing 100021, Peoples R China 2.中国科学院合肥物质科学研究院肿瘤医院 3.University Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA |
推荐引用方式 GB/T 7714 | Zhang Ye,Xiao Jianping,Zhang Hongzhi,et al. Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution[J]. CHINESE MEDICAL JOURNAL,2011,124. |
APA | Zhang Ye.,Xiao Jianping.,Zhang Hongzhi.,Yin Weibo.,Hu Yimin.,...&Li Yexiong.(2011).Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution.CHINESE MEDICAL JOURNAL,124. |
MLA | Zhang Ye,et al."Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution".CHINESE MEDICAL JOURNAL 124(2011). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。